Singapore markets close in 7 hours 14 minutes
Straits Times Index
3,264.40 -28.73 (-0.87%) Nikkei
37,907.39 -552.69 (-1.44%) Hang Seng
17,167.62 -33.65 (-0.20%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,355.03 -2,498.18 (-3.74%) CMC Crypto 200
1,394.41 -29.69 (-2.08%)
ABBV Dec 2025 220.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:46AM EDT. Market open.
| Previous close | 73.80 |
| Open | N/A |
| Bid | 82.20 |
| Ask | 85.85 |
| Strike | 220.00 |
| Expiry date | 2025-12-19 |
| Day's range | 73.80 - 73.80 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.